Two Harbors Investment Corp. (NYSE:TWO) shares moved down -0.22% in last trading session and ended the day at $8.89. TWO Gross Margin is 65.60% and its has a return on assets of 2.40%. Two Harbors Investment Corp. (NYSE:TWO) quarterly performance is -9.59%.
Two Harbors Investment Corp. (NYSE:TWO) announced that it will release financial results for the quarter ended September 30, 2015 after the market close on November 4, 2015. The company will host a conference call to review the financial results on November 5, 2015, at 9:00 a.m. EST.
Northwest Pipe Co. (NASDAQ:NWPX) ended the last trading day at $14.21. Company weekly volatility is calculated as 7.79% and price to cash ratio as 194.27. Northwest Pipe Co. (NASDAQ:NWPX) showed a weekly performance of -2.00%.
On 6 October, it was reported Northwest Pipe Company (NASDAQ: NWPX), was selected by Southland Contracting, Inc. of Fort Worth, Texas to provide 2,250 feet of 108-inch diameter steel water pipe for the Schoharie Reservoir Low Level Outlet Tunnel Project. This pipe will be manufactured at Northwest Pipe’s Permalok® facility in St. Louis, Missouri. The Permalok® steel tunnels will be installed in the vicinity of the Gilboa Dam in Schoharie County, New York, using micro tunneling technology. The project is anticipated to be substantially completed by the end of 2020 and is owned by New York City Department of Environmental Protection.
On 20 October, MacroGenics, Inc. (NASDAQ:MGNX) shares moved down -1.95% and was closed at $28.71. MacroGenics, Inc. (NASDAQ:MGNX) year to date (YTD) performance is -18.14%.
On 13 October, MacroGenics, Inc. (NASDAQ:MGNX), held its first R&D Day and provided an in-depth review of the Company’s broad portfolio of product candidates and technology platforms. Special guest speakers included Charles Drake, M.D., Ph.D., Professor of Oncology, Urology and Immunology, Johns Hopkins School of Medicine, and Holbrook Kohrt, M.D., Ph.D., Assistant Professor of Medicine (Oncology) at Stanford University Medical Center.
Flex Pharma, Inc. (NASDAQ:FLKS) shares moved down -2.72% in last trading session and ended the day at $10.38. FLKS has a return on assets of -25.80%. Flex Pharma, Inc. (NASDAQ:FLKS) quarterly performance is -36.12%.
Flex Pharma, Inc. (NASDAQ:FLKS), announced that it presented data demonstrating GMP-synthesized single agent efficacy and a dose response in significantly reducing human muscle cramp intensity in its electrically induced cramp model at the Society for Neuroscience in Chicago, IL.
Xenoport, Inc. (NASDAQ:XNPT) caters to the Healthcare space. Its weekly performance is -2.80%. On the last day of trading company shares ended up at $4.86. Xenoport, Inc. (NASDAQ:XNPT) distance from 50-day simple moving average (SMA50) is -10.63%.
On 1st October, XenoPort, Inc. (NASDAQ: XNPT) announced a strategic shift to focus on and maximize the value of its commercial product, HORIZANT® (gabapentin enacarbil) Extended Release Tablets. As part of this shift, XenoPort will discontinue development of XP23829 on its own and seek to partner this and other high potential development stage assets.
Leave a Reply